Success Metrics

Clinical Success Rate
96.0%

Based on 48 completed trials

Completion Rate
96%(48/50)
Active Trials
4(6%)
Results Posted
38%(18 trials)
Terminated
2(3%)

Phase Distribution

Ph phase_1
2
3%
Ph phase_4
10
15%
Ph early_phase_1
2
3%
Ph not_applicable
23
35%
Ph phase_2
17
26%
Ph phase_3
10
15%

Phase Distribution

4

Early Stage

17

Mid Stage

20

Late Stage

Phase Distribution64 total trials
Early Phase 1First-in-human
2(3.1%)
Phase 1Safety & dosage
2(3.1%)
Phase 2Efficacy & side effects
17(26.6%)
Phase 3Large-scale testing
10(15.6%)
Phase 4Post-market surveillance
10(15.6%)
N/ANon-phased studies
23(35.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.0%

48 of 50 finished

Non-Completion Rate

4.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

65

all time

Status Distribution
Active(4)
Completed(48)
Terminated(2)
Other(11)

Detailed Status

Completed48
unknown11
Recruiting3
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
65
Active
4
Success Rate
96.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.1%)
Phase 12 (3.1%)
Phase 217 (26.6%)
Phase 310 (15.6%)
Phase 410 (15.6%)
N/A23 (35.9%)

Trials by Status

completed4874%
recruiting35%
terminated23%
active_not_recruiting12%
unknown1117%

Recent Activity

Clinical Trials (65)

Showing 20 of 65 trialsScroll for more
NCT07366086Phase 3

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

Recruiting
NCT04850222Phase 2

Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma

Completed
NCT04067726Phase 2

RANKL Inhibition and Mammographic Breast Density

Active Not Recruiting
NCT07491601Not Applicable

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Recruiting
NCT05884372Phase 4

Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)

Completed
NCT06930391Not Applicable

Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

Recruiting
NCT05035316Phase 2

Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)

Completed
NCT03629717Early Phase 1

RANKL Inhibition and Breast Tissue Biomarkers

Completed
NCT00365105Phase 3

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Completed
NCT04545554Phase 1

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Completed
NCT02944799Phase 2

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis

Completed
NCT02338687Phase 4

Low Dose Calcium to Prevent Preeclampsia

Completed
NCT02589600Phase 4

Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)

Completed
NCT06022237Not Applicable

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Unknown
NCT03118570Phase 2

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Completed
NCT05860062Not Applicable

Vitamin D Supplementation in Episodic and Chronic Tension-type Headache

Unknown
NCT04823156Not Applicable

The Effect of Calcium Intake on Calcium and Bone Metabolism During Load Carriage in Women

Unknown
NCT02195895Phase 2

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

Completed
NCT05275491

Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients

Completed
NCT05691959Phase 2

Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
65